Loading stock data…
EHAB
$13.75+0.01 (+0.07%)
Market ClosedLast close May 1
Enhabit, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Enhabit, Inc. in the Healthcare sector is trading at $13.75. The stock is currently near its 52-week high of $14.22, remaining 38.2% above its 200-day moving average. Technical signals show oversold RSI of 17 and bearish MACD signal, explaining why EHAB maintains its current momentum and trend strength. The Whystock Score of 75/100 reflects a high-conviction bullish alignment.
Ecosystem Influences
Oversold momentum (RSI 17) — potential for technical mean-reversion
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$13.75
Potential Upside
5%
Whystock Fair Value$14.44
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$703.58M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.08
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-24.94%
Volume
Today's trading volume
956,292
Recent News
How The Enhabit (EHAB) Narrative Is Resetting Around Kinderhook’s US$13.80 Cash Offer
Enhabit’s fair value price target has been reset to US$13.80 from US$13.83, effectively in line with the agreed Kinderhook all cash offer. Street research is now clustering around this US$13.80 level, with bullish and bearish analysts using the same deal price to frame very different views on remaining upside and risk. Read on to see how this reset is shaping the evolving narrative and what to watch from here. Analyst Price Targets don't always capture the full story. Head over to our Company...
How The Enhabit (EHAB) Story Is Shifting Toward Kinderhook’s US$13.80 Cash Deal
The consensus fair value estimate for Enhabit has shifted only slightly, from about US$13.80 to roughly US$13.83 per share, staying closely in line with the agreed US$13.80 cash offer. That tiny move matches the way recent analyst commentary has pivoted toward the deal price itself, with target changes largely reflecting the acquisition terms rather than a fresh view on long term potential. As you read on, you will see how this tighter price anchoring shapes the evolving analyst narrative and...
How The Enhabit (EHAB) Story Is Shifting After The Kinderhook US$13.80 Cash Offer
Enhabit’s fair value price target is holding at $13.80 per share, directly matching the agreed all cash acquisition price and keeping the deal front and center for investors. That alignment reflects how bullish and bearish analyst views now cluster around the offer level, with prior optimism on regulatory trends and reimbursement contrasted with more neutral stances that see limited upside versus the cash bid. As you read on, you will see how to track this evolving narrative and what it means...
Enhabit (EHAB) Q3 2025 Earnings Call Transcript
With me on the call this morning is Barb Jacobsmeyer, President and Chief Executive Officer; and Ryan Solomon, Chief Financial Officer. Before we begin, I want to let you know that our third quarter earnings release and supplemental information are available on our website at investors.ehab.com. On Page 2 of the supplemental information, you will find the safe harbor statements, which are also set forth in the last page of our earnings release.
Enhabit (EHAB) Q1 2025 Earnings Call Transcript
Before we begin, if you do not already have a copy, the first quarter earnings release, supplemental information and related Form 8-K filed with the SEC are available on our website at investors.ehab.com. On Page 2 of the supplemental information, you will find the Safe Harbor statements, which are also set forth on the last page of the earnings release.